000 | 01717 a2200457 4500 | ||
---|---|---|---|
005 | 20250516024419.0 | ||
264 | 0 | _c20110629 | |
008 | 201106s 0 0 eng d | ||
022 | _a1530-0307 | ||
024 | 7 |
_a10.1038/labinvest.2011.11 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDing, Zhaobing | |
245 | 0 | 0 |
_aAn orally available small imidazolium salt ameliorates inflammation and fibrosis in a murine model of cholestasis. _h[electronic resource] |
260 |
_bLaboratory investigation; a journal of technical methods and pathology _cMay 2011 |
||
300 |
_a752-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCholestasis _xdrug therapy |
650 | 0 | 4 |
_aCollagen _xmetabolism |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
650 | 0 | 4 |
_aFibrosis _xdrug therapy |
650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
700 | 1 | _aKng, Yinling | |
700 | 1 | _aYang, Henry | |
700 | 1 | _aKe, Zhiyuan | |
700 | 1 | _aZhuo, Lang | |
773 | 0 |
_tLaboratory investigation; a journal of technical methods and pathology _gvol. 91 _gno. 5 _gp. 752-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/labinvest.2011.11 _zAvailable from publisher's website |
999 |
_c20616110 _d20616110 |